Dose-comparative monotherapy trials of ZD1839 in previously treated non-small cell lung cancer patients

被引：34
|
作者：
Herbst, RS [1 ]
机构：
[1] MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Unit 432, Houston, TX 77030 USA
来源：
SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 01期
关键词：
D O I：
10.1053/sonc.2003.50030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：30 / 38
页数：9
相关论文
共 50 条
  • [1] Gefitinib (ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancer
    Park, J
    Park, BB
    Kim, JY
    Lee, SH
    Lee, SI
    Kim, HY
    Kim, JH
    Park, SH
    Lee, KE
    Park, JO
    Kim, K
    Jung, CW
    Park, YS
    Im, YH
    Kang, WK
    Lee, MH
    Park, K
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (13) : 4383 - 4388
  • [2] ZD1839 (Iressa™) in non-small cell lung cancer
    Herbst, RS
    Kies, MS
    [J]. ONCOLOGIST, 2002, 7 : 9 - 15
  • [3] Evaluation of safety and efficacy of ZD1839 as monotherapy for Chinese patients with advanced non-small cell lung cancer.
    Zhang, XT
    Li, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 639S - 639S
  • [4] ZD1839 for the treatment of heavily pretreated non-small cell lung cancer.
    Wu, YL
    Yang, X
    Yang, JJ
    Huang, YJ
    Chen, G
    Gu, LJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 701S - 701S
  • [5] ZD1839 (Iressa™):: For more than just non-small cell lung cancer
    Ranson, M
    [J]. ONCOLOGIST, 2002, 7 : 16 - 24
  • [6] Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, 'Iressa') on an expanded access study
    Dongiovanni, Vincenzo
    Dongiovanni, Diego
    Buffoni, Lucio
    Barone, Carla
    Fissore, Camilla
    Addeo, Alfredo
    Larovere, Erika
    Grillo, Raffaella
    Nuzzolo, Gloria
    Schena, Marina
    Bertetto, Oscar
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 21 - 22
  • [7] Gefitinib ('IRESSA', ZD1839) in patients with non-small cell lung cancer (NSCLC): The Royal Marsden experience
    Maisey, NR
    Parton, M
    Harper-Wynne, C
    Sumpter, K
    Ashley, S
    Eisen, T
    O'Brien, M
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 : S15 - S15
  • [8] Commentary on ZD1839 (Iressa) in non small lung cancer
    Ranson, M
    Thatcher, N
    [J]. LUNG CANCER, 2003, 40 (01) : 77 - 78
  • [9] Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor
    Lee, MW
    Seo, CW
    Kim, SW
    Yang, HJ
    Lee, HW
    Choi, JH
    Moon, KC
    Koh, JK
    [J]. ACTA DERMATO-VENEREOLOGICA, 2004, 84 (01) : 23 - 26
  • [10] Gefitinib (ZD1839):: Therapy in selected patients with non-small cell tung cancer (NSCLC)?
    Dongiovanni, Diego
    Daniele, Lorenzo
    Barone, Carla
    Dongiovanni, Vincenzo
    Fissore, Camilla
    Sapino, Anna
    Macri, Luigia
    Bussolati, Giovanni
    Buffoni, Lucio
    Gaspari, Fabio
    Grillo, Raffaella
    Birocco, Nadia
    Addeo, Alfredo
    Ciuffreda, Libero
    Schena, Marina
    [J]. LUNG CANCER, 2008, 61 (01) : 73 - 81
12345